Synergistic effect of methotrexate and infliximab on activated lymphocyte apoptosis [1]

Inflammatory Bowel Diseases

Volumn 13, Issue 1, 2007, Pages 118-119

  Van Den Brande, Jan M H ^a   Peppelenbosch, Maikel P ^b   Hommes, Daan W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CROHN DISEASE; DENDRITIC CELL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; LETTER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; APOPTOSIS; DRUG SYNERGISM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; METHOTREXATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846155252     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20000     Document Type: Letter

References (8)

1. Furst DE. The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases. Br J Rheumatol. 1997;36:1196-1204.
2. Saporito FC, Menter MA. Methotrexate and psoriasis in the era of new biologic agents. J Am Acad Dermatol. 2004;50:301-309.
3. Feagan BG, Fedorak RN, Irvine EJ, et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. N Engl J Med. 2000;342:1627-1632.
4. Genestier L, Paillot R, Fournel S, et al. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest. 1998;102:322-328.
5. Lemann M, Zenjari T, Bouhnik Y, et al. Methotrexate in Crohn's disease: longterm efficacy and toxicity. Am J Gastroenterol. 2000;95:1730-1734.
6. Schröder O, Stein J. Low dose methotrexate in inflammatory bowel disease: current status and future directions. Am J Gastroenterol. 2003;98:530-537.
7. Braat H, van den Brande J, van Tol E, et al. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am J Clin Nutr. 2004;80:1618-1625.
8. Van den Brande JM, Braat H, van den Brink GR, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology. 2003;124:1774-1785.